Biartrin (Biartrin)

Archive
"Trade product
in Russia is not registered "
Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Active substanceGlycosaminoglycan-peptide complexGlycosaminoglycan-peptide complex
Similar drugsTo uncover
  • Biartrin
    solution w / m 
    BINERGIYA, CJSC     Russia
  • Rumalon
    solution w / m 
    BRYNTSALOV-A, CJSC     Russia
    • Dosage form: & nbspsolution for intramuscular injection
    Composition:
    1 ml of the preparation contains:
    Active ingredients: 2.5 mg glycosaminoglycan-peptide complex derived from cartilage and red bone marrow calves and
    auxiliary substances: metacresol 2.5 mg, water for injection up to 1 ml.
    Description:
    Transparent solution of a yellowish-brown color with a smell of metasrezole.
    Pharmacotherapeutic group:Reparation of tissue stimulant
    ATX: & nbsp

    M.09.A.X   Other drugs for the treatment of diseases of the musculoskeletal system

    Pharmacodynamics:

    Combined preparation of animal origin, contains glycosaminoglycan-peptide complex. The effect of the drug is due to the combined effect of its active components. Normalizes the metabolism in the cartilaginous hyaline tissue enhances the biosynthesis of sulfated mucopolysaccharides and collagen, stimulates the regeneration of articular cartilage, reduces the activity of enzymes and inhibits catabolic processes in the cartilaginous tissue.

    Pharmacokinetics:

    Studies have not been conducted.

    Indications:

    Degenerative and dystrophic joint diseases: gonarthrosis, arthrosis of interphalangeal joints, coxarthrosis, spondylosis, spondyloarthrosis, meniscopathy, patellar chondromalacia.

    Contraindications:

    Hypersensitivity to the components of the drug, rheumatoid arthritis, pregnancy and lactation, age under 18 years, use in women of reproductive age not observing reliable methods of contraception.

    Pregnancy and lactation:

    Data on the use of the drug during pregnancy and during breastfeeding are absent. Application in pregnancy and lactation is not recommended. Women of reproductive age in the period of treatment with Biartrin observe reliable methods of contraception.

    Dosing and Administration:

    The drug is administered intramuscularly: on the first day - 0.3 ml, on the second day - 0.5 ml, then - 1 ml (1 ampoule) 3 times a week for 5-6 weeks.

    Repeated course of treatment - after consultation with a doctor according to the same scheme.

    Side effects:

    Allergic reactions (rare), anaphylactoid reactions, including anaphylactic shock.

    If any of the side effects indicated in the manual are aggravated or you notice any other side effects not listed in the instructions, inform your doctor.

    Overdose:

    Data on drug overdose are unknown.

    Interaction:

    It can be used simultaneously with non-steroidal anti-inflammatory drugs and glucocorticosteroids. When used simultaneously with indirect anticoagulants, antiplatelet agents and fibrinolytic agents, their effect may be enhanced.

    Special instructions:

    When used simultaneously with indirect anticoagulants, antiplatelet agents, fibrinolytic drugs, frequent monitoring of blood clotting parameters is necessary.

    Information about the effect on the ability to drive vehicles and work with mechanisms that require an increased speed of psychomotor reactions, no.

    Form release / dosage:

    Solution for intramuscular injection.

    Packaging:

    1 ml per ampoule of light-protective glass with a capacity of 2 ml of brand SNS-1.

    5 ampoules are placed in a contour plastic package (tray) made of a polyvinylchloride film or a polyethylene terephthalate film.

    5 ampoules are placed in a contour mesh box made of a polyvinylchloride film or a polyethylene terephthalate film and a foil of aluminum printed lacquered or packaging material.

    1, 2 contour plastic packages (pallets) or contour mesh packages together with the instruction for use are placed in a pack of cardboard.

    5,10 The ampoule, together with the instruction for use, is placed in a bundle with a separating insert of cardboard.

    Storage conditions:

    In the dark place at a temperature of no higher than 20 ° C.

    Keep out of the reach of children.

    Shelf life:

    5 years.

    Do not use after the expiry date printed on the package.

    Terms of leave from pharmacies:On prescription
    Registration number:LP-000606
    Date of registration:21.09.2011 / 11.12.2013
    Expiration Date:21.09.2016
    The owner of the registration certificate:BINERGIYA, CJSC BINERGIYA, CJSC Russia
    Manufacturer: & nbsp
    Information update date: & nbsp25.01.2017
    Illustrated instructions
      Instructions
      Up